Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Press

Showing results (141-150 of 273) with videos related to

Pageof 28
Sort By:
Breast Cancer Research : BCR|July 17, 2008
The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancerNuran Bektas, Erik Noetzel, Jürgen Veeck, et al.
JAMA Oncology|June 10, 2016
Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without LapatinibAleix Prat, Maggie C U Cheang, Patricia Galván, et al.
Anticancer Research|November 1, 1996
Chicken ovalbumin upstream promoter--transcription factor (COUP-TF) expression in human endometrial cancer cell linesD G Kieback, T Levi, P Kohlberger, et al.
Breast Cancer Research and Treatment|November 25, 2024
Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markersDorothea Hanf, Peter Fasching, Paul Gass, et al.
Cancer Research|April 19, 2007
A variant in the cytochrome p450 oxidoreductase gene is associated with breast cancer risk in African AmericansChristopher A Haiman, V Wendy Setiawan, Lucy Y Xia, et al.
Cancers|June 10, 2022
Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast CancerAdam L Maddox, Matthew S Brehove, Kiarash R Eliato, et al.
Molecular Cancer Therapeutics|June 20, 2023
Discordance of HER2 Expression and/or Amplification on Repeat TestingTimothy P DiPeri, Kathleen Kong, Kaushik Varadarajan, et al.
Cancer Genetics and Cytogenetics|February 12, 2008
Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American womenVeronica Wendy Setiawan, Li-Hao Chu, Esther M John, et al.
Breast Cancer Research and Treatment|March 17, 2005
Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium 'Breast Cancer--The Development and Validation of New Therapeutics'Marc E Lippman, Chris Benz, Arul Chinnaiyan, et al.
Protein Engineering, Design & Selection : PEDS|June 10, 2004
Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targetingTove Olafsen, Giselle J Tan, Chia-Wei Cheung, et al.
Pageof 28

Showing results (141-150 of 273) with videos related to

Sort By:
Pageof 28
Breast Cancer Research : BCR|July 17, 2008
The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancerNuran Bektas, Erik Noetzel, Jürgen Veeck, et al.
JAMA Oncology|June 10, 2016
Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without LapatinibAleix Prat, Maggie C U Cheang, Patricia Galván, et al.
Anticancer Research|November 1, 1996
Chicken ovalbumin upstream promoter--transcription factor (COUP-TF) expression in human endometrial cancer cell linesD G Kieback, T Levi, P Kohlberger, et al.
Breast Cancer Research and Treatment|November 25, 2024
Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markersDorothea Hanf, Peter Fasching, Paul Gass, et al.
Cancer Research|April 19, 2007
A variant in the cytochrome p450 oxidoreductase gene is associated with breast cancer risk in African AmericansChristopher A Haiman, V Wendy Setiawan, Lucy Y Xia, et al.
Cancers|June 10, 2022
Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast CancerAdam L Maddox, Matthew S Brehove, Kiarash R Eliato, et al.
Molecular Cancer Therapeutics|June 20, 2023
Discordance of HER2 Expression and/or Amplification on Repeat TestingTimothy P DiPeri, Kathleen Kong, Kaushik Varadarajan, et al.
Cancer Genetics and Cytogenetics|February 12, 2008
Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American womenVeronica Wendy Setiawan, Li-Hao Chu, Esther M John, et al.
Breast Cancer Research and Treatment|March 17, 2005
Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium 'Breast Cancer--The Development and Validation of New Therapeutics'Marc E Lippman, Chris Benz, Arul Chinnaiyan, et al.
Protein Engineering, Design & Selection : PEDS|June 10, 2004
Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targetingTove Olafsen, Giselle J Tan, Chia-Wei Cheung, et al.
Pageof 28